Trau group researchers are using nanotechnology for fabrication-free disease biomarker detection within a fluidic droplet. The “lab-in-a-drop” system can be extremely useful for the detection of disease nucleic acid biomarkers.
A new National Health and Medical Research Council (NHMRC) grant was announced today which will support research to develop new treatments for cancer at The University of Queensland.
